Market Research Report
Middle East and Africa Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
|Middle East and Africa Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027|
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 100 Pages
Delivery time: 3-5 business days
Middle East and Africa alopecia treatment (hair loss) market is projected to register a CAGR of 4.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Middle East and Africa Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Cicatricial Alopecia, Traction Alopecia and Others), Treatment (Localized Therapies, Systemic Therapies, Medical Devices and Herbal Treatment), Gender (Male and Female), Form (Oral, Topical and Parenteral), End User (Hospital, Home Healthcare and Dermatology Centers), Distribution Channel (Direct Tender, Retail Sales and Pharmacies), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2027
Increasing prevalence of chemotherapy induced alopecia
Increasing level of stress
Johnson & Johnson Services, Inc.
Taisho Pharmaceutical Holdings Co., Ltd.
Sun Pharmaceutical Industries Ltd.
Pfizer Inc., Cipla Inc.
Dr. Kurt Wolff Gmbh & Co. KG.
Dr. Reddy's Laboratories Ltd.
Gerolymatos International SA
Labo International S.R.L.
Perrigo Company Plc.
Vita-Cos-Med Klett-Loch Gmbh.
Won Tech Co., Ltd.